We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$93.4B
AUM Growth
+$1.44B
Cap. Flow
-$783M
Cap. Flow %
-0.84%
Top 10 Hldgs %
32.36%
Holding
7,324
New
436
Increased
3,303
Reduced
2,734
Closed
395

Sector Composition

Rank Sector Weight
1 Technology 6.12%
2 Healthcare 4.92%
3 Financials 4.07%
4 Consumer Discretionary 3.64%
5 Communication Services 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGI
5501
PUT
DELISTED
DigitalGlobe Inc.
DGI
$33K ﹤0.01%
1,000
-4,200
-81% -$135K
EMXX
5502
DELISTED
Eurasian Minerals Inc
EMXX
$33K ﹤0.01%
36,000
LJPC
5503
CALL
DELISTED
La Jolla Pharmaceutical Company
LJPC
$33K ﹤0.01%
+1,100
New +$31.5K
ALB icon
5504
CALL
Albemarle
ALB
$15.5B
$32K ﹤0.01%
300
-18,200
-98% -$1.98M
DCO icon
5505
CALL
Ducommun
DCO
$2.98B
$32K ﹤0.01%
1,000
DEO icon
5506
Diageo
DEO
$53.6B
$32K ﹤0.01%
271
-3,600
-93% -$429K
DGII icon
5507
Digi International
DGII
$3.1B
$32K ﹤0.01%
3,155
+2,836
+889% +$30.1K
HOUS
5508
PUT
DELISTED
Anywhere Real Estate
HOUS
$32K ﹤0.01%
1,000
+700
+233% +$21.2K
IPI icon
5509
Intrepid Potash
IPI
$469M
$32K ﹤0.01%
1,438
-12,137
-89% -$254K
MCHI icon
5510
iShares MSCI China ETF
MCHI
$6.38B
$32K ﹤0.01%
597
OPOF
5511
DELISTED
Old Point Financial
OPOF
$32K ﹤0.01%
988
-212
-18% -$6.44K
RES icon
5512
PUT
RPC Inc
RES
$1.3B
$32K ﹤0.01%
1,600
+600
+60% +$11.4K
TPC
5513
CALL
Tutor Perini Cor
TPC
$5.21B
$32K ﹤0.01%
1,100
+400
+57% +$11.4K
LUMO
5514
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$32K ﹤0.01%
489
+389
+389% +$48.2K
OXFD
5515
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$32K ﹤0.01%
1,919
+1,383
+258% +$20.7K
NXTM
5516
DELISTED
NxStage Medical Inc.
NXTM
$32K ﹤0.01%
1,256
-12,360
-91% -$306K
CALL
5517
CALL
DELISTED
magicJack VocalTec Ltd
CALL
$32K ﹤0.01%
+4,400
New +$33.5K
NDRM
5518
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$32K ﹤0.01%
1,071
+35
+3% +$907
AIZ icon
5519
PUT
Assurant
AIZ
$14.3B
$31K ﹤0.01%
+300
New +$29.9K
BELFB
5520
Bel Fuse Inc Class B
BELFB
$4.21B
$31K ﹤0.01%
1,241
+1,146
+1,206% +$27.6K
CMRE icon
5521
Costamare
CMRE
$1.77B
$31K ﹤0.01%
4,326
-42,951
-91% -$300K
FLGT icon
5522
Fulgent Genetics
FLGT
$527M
$31K ﹤0.01%
4,800
+3,778
+370% +$30.5K
KOPN icon
5523
Kopin
KOPN
$791M
$31K ﹤0.01%
8,398
-16,658
-66% -$62.7K
NTCT icon
5524
CALL
NETSCOUT
NTCT
$2.79B
$31K ﹤0.01%
900
-2,100
-70% -$76K
RARE icon
5525
PUT
Ultragenyx Pharmaceutical
RARE
$2.55B
$31K ﹤0.01%
500

Similar funds

Barclays's Q2 2017 Portfolio in Review

As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.

  • Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
  • Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
  • Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
  • Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
  • Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
  • Barclays opened 436 new positions and closed 395 in Q2 2017.
  • Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.

Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.